Forecasting unanticipated consequences of "the sunshine act": Mostly cloudy

Journal of Clinical Oncology

Volumn 32, Issue 22, 2014, Pages 2293-2295

  Ratain, Mark J ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG INDUSTRY; FOOD AND DRUG ADMINISTRATION; FORECASTING; HEALTH CARE POLICY; HUMAN; MARKETING; MEDICAL FEE; MEDICAL PRACTICE ACT; MEDICAL SOCIETY; MERGERS AND ACQUISITIONS; NOTE; PHYSICIAN; PRIORITY JOURNAL; THE SUNSHINE ACT; TRANSLATIONAL RESEARCH;

CONFLICT OF INTEREST; DRUG INDUSTRY; FEES AND CHARGES; HUMANS; PATIENT PROTECTION AND AFFORDABLE CARE ACT; PHYSICIANS; UNITED STATES;

EID: 84905819376     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2014.55.4592     Document Type: Note

References (13)

1. United States Senate, 110th Congress, First Session: S. 2029: Physician Payments Sunshine Act of 2007. http://www.gpo.gov/fdsys/pkg/BILLS-110s2029is/ pdf/BILLS-110s2029is.pdf
2. House of Representatives, 111th Congress, Second Session: H.R. 3590: Patient Protection and Affordable Care Act. http://www.gpo.gov/fdsys/pkg/BILLS- 111hr3590enr/pdf/BILLS-111hr3590enr.pdf
3. Department of Health and Human Services, Centers for Medicare & Medicaid Services: Federal Register, Final Rule: Medicare, Medicaid, Children's Health Insurance Programs; Transparency Reports and Reporting of Physician Ownership or Investment Interests. http://www.cms.gov/Regulations-and-Guidance/ Legislation/National-Physician-Payment-Transparency-Program/Downloads/ Final-Rule.pdf
4. Robertson C, Rose S, Kesselheim AS: Effect of financial relationships on the behaviors of health care professionals: A review of the evidence. J Law Med Ethics 40:452-466, 2012
5. Cohen J, Malins A, Shahpurwala Z: Compared to US practice, evidence-based reviews in Europe appear to lead to lower prices for some drugs. Health Aff (Millwood) 32:762-770, 2013
6. Centers for Medicare & Medicaid Services (CMS): Open Payments: Creating Public Transparency Into Industry-Physician Financial Relationships - User Guide for Industry. http://www.cms.gov/Regulations-and-Guidance/ Legislation/National-Physician-Payment-Transparency-Program/Downloads/ OPEN-PAYMENTS-User-Guide-[August-2013].pdf
7. Senator Chuck Grassley of Iowa News Web Site: Grassley, Kohl say public should know when pharmaceutical makers give money to doctors: McCaskill, Schumer, Klobuchar and Kennedy co-sponsor new Grassley-Kohl legislation. September 6, 2007. http://www.grassley.senate.gov/news/Article.cfm?customel- dataPageID-1502=10297
8. Madara JL: Letter to Centers for Medicare & Medicaid Services Re: Medicare, Medicaid, Children's Health Insurance Programs; Transparency Reports and Reporting of Physician Ownership or Investment Interests. http://www.ama-assn.org/resources/doc/washington/aging-rountable-sunshine- letter-10oct2012.pdf
9. Stone K: Pharmas and Corporate Philanthropy. http://pharma.about.com/od/ Philanthropy/a/Pharmas-And-Corporate-Philanthropy.htm
10. American Society of Clinical Oncology: American Society of Clinical Oncology: Policy for relationships with companies. J Clin Oncol 31:2043-2046, 2013
11. United States Senate, 112th Congress, Second Session: Let the Sunshine In: Implementing the Physician Payments Sunshine Act. Roundtable before the Special Committee on Aging. http://www.gpo.gov/fdsys/pkg/CHRG-112shrg76453/pdf/ CHRG-112shrg76453.pdf
12. National Institutes of Health, ClinicalTrials.gov: FDAAA 801 Requirements. http://clinicaltrials.gov/ct2/manage-recs/fdaaa
13. U.S. House of Representatives, 110th Congress: Public Law 110-85. Food and Drug Administration Amendments Act of 2007. http://www.gpo.gov/fdsys/pkg/ PLAW-110publ85/pdf/PLAW-110publ85.pdf